Contentscontinued xvi
Section 5 Immunology Review, 367
Immunology Terminology, 368
Branches of the Immune System, 372
Types of Immunity, 373
Adaptive Immunity, 374
Cells of the Natural Immune System,
375
Cells of the Acquired Immune System,
377
Subpopulations of Lymphocytes, 378
Lymphoid Organs, 379
Isolation & Identification of
Lymphocytes, 380
Immunoglobulin (Ig) Structure, 381
Immunoglobulins, 383
Complement, 385
Hypersensitivity Reactions, 387
Agglutination Methods, 388
Precipitation Methods, 389
Immunoassay Terminology, 390
Enzyme Immunoassay (EIA)
Terminology, 391
Enzyme Immunoassays (EIA) Formats,
392
Fluorescent Immunoassays (FIA), 394Comparison of Labeled Immunoassays,
395
Nontreponemal Tests for Syphilis, 397
Treponemal Tests for Syphilis, 398
Interpretation of Syphilis Test Results,
400
Serological Tests for Other Bacterial
Infections, 401
Serological Tests for Infectious
Mononucleosis (IM), 402
Hepatitis Tests, 403
Hepatitis Serological Profiles, 405
Appearance of HIV Markers, 406
HIV Screening Tests, 407
False Positives and Negatives With HIV-
Antibody ELISA Testing, 408
HIV Confirmatory/Supplemental Tests,
409
Tests to Stage and Monitor HIV, 410
Screening Tests for Systemic Lupus
Erythematosus (SLE), 411
Tests for Specific Antinuclear Antibodies
(ANA), 412
Serological Tests for Rheumatoid
Arthritis (RA), 413Interpretation of Serological Tests,
414
Serology Calculations, 415
Section 6 Immunohematology Review, 417
Criteria for Whole Blood Donors (AABB),
418
Donor Deferrals (AABB), 419
Collection of Whole Blood, 421
Apheresis, 422
Donor Testing Required by AABB and/or
FDA, 423
Anticoagulant/Preservative Solutions,
424
Additive Solutions, 425
Open and Closed Systems, 426
Blood Components—RBCs, 427
Blood Components—Plasma and
Derivatives, 429
Blood Components—Platelets, 430
Labeling Requirements for Blood and
Components, 431
Leukocyte Reduction (Leukoreduction),
432
RBC Storage Lesion, 433
continued...2956_FM_i-xxii 29/01/14 11:55 AM Page xvi